155513-80-7 Usage
Purpose
Used in the treatment of Major Depressive Disorder (MDD)
Drug Class
Serotonin modulators and stimulators (SMSs)
Mechanism of Action
Increases levels of serotonin in the brain, selective serotonin reuptake inhibitor (SSRI), serotonin receptor modulator
Serotonin Receptor Modulation
Modulation of several serotonin receptors
FDA Approval
Approved for the treatment of MDD
Clinical Trial Results
Promising results in improving symptoms of depression and anxiety
Potential Side Effects
May have potential side effects and should be used under the guidance of a healthcare professional
Check Digit Verification of cas no
The CAS Registry Mumber 155513-80-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,5,1 and 3 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 155513-80:
(8*1)+(7*5)+(6*5)+(5*5)+(4*1)+(3*3)+(2*8)+(1*0)=127
127 % 10 = 7
So 155513-80-7 is a valid CAS Registry Number.
155513-80-7Relevant articles and documents
Dihalogentriphenylphosphoranes in the synthesis of heterocycles, 29. A simple synthesis of pteridin-4-ones, from methyl-3-amino-2-pyrazinecarboxylate and pyrazino[3,1]oxazin-4-ones
Wamhoff,Kroth
, p. 405 - 410 (2007/10/02)
Methyl 3-amino-2-pyrazinecarboxylate (3) affords the synthetically useful 3-aroylaminopyrazin-2-carboxylates 5a-f with aroyl chlorides, which are converted with dibromotriphenylphosphorane into 2-arylpyrazino[2,3-d][3,1]oxazin-4-ones 6a-f. Nucleophilic attack at the carbonyl function of these oxazinones results in ring cleaved amides which can be recyclized with dibromotriphenylphosphorane to afford 2-arylpteridin-4-ones 7a-f.